Page 46 - Dukungan BPOM Dalam Vaksinasi Massal Vaksin Inavac

Judul : 1.2 Million Local Made COVID-19 Vaccines Start Distribution To Regions In
Indonesia
Nama Media : voi.id
Tanggal : 30/05/2023
Halaman/URL : https://voi.id/en/news/283451
Tipe Media : Media Online

The private pharmaceutical
industry PT Biotis
Pharmaceuticals Indonesia has
distributed a total of 1.2 million
doses of InaVac's COVID-19
vaccine ordered by the
government to all regions in
Indonesia.

"The Minister of Health
(Menkes) has issued a Decree
on the purchase of InaVac 5
million doses, 1.2 million more
doses of which have been
realized and distributed to all
provinces," said PT Biotis Pharmaceutical Indonesia President Director FX Sudirman quoted by
ANTARA, Tuesday 30 May.

A total of more than 3.7 million doses of vaccines ordered by the government, he said, were prepared
to refill the needs of the people who were completed in the near future.

He said Biotis was conducting further clinical trials for teenagers who are now rolling at Soetomo
Hospital, Surabaya.

"We have also started preparations for child vaccination to be carried out in the next quarter to obtain
an Emergency Use Permit (EUA) for teenagers, especially school children who receive a booster dose
of InaVac," he said.

FX Sudirman said Biotis and the researchers were trying to pay attention to the quality of vaccines,
including efforts to maintain vaccine efficacy.

"This vaccine has been designed halally and this is a positive point, both primary and booster," he said.